Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Macrogenics, Raises Price Target to $16

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.
byBenzinga Newsdesk
August 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0